GlassScriptPhysician profile
Tareq Abedin
NPI 1336109610
$5,665.95
in general payments reported to CMS, 2019-2025
37 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $218 · 2021: $321 · 2022: $1,201 · 2023: $1,198 · 2024: $1,047 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,642.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,450.19 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $670.99 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $668.18 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $406.37 | 2019-2025 | Bexsero, Pediarix, Trelegy Ellipta |
| Pfizer INC. | $387.55 | 2019-2025 | |
| Cepheid | $313.89 | 2022 | |
| Lilly USA, LLC | $271.76 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Astellas Pharma US INC | $244.20 | 2019-2025 | Veozah, Myrbetriq |
| Vanda Pharmaceuticals INC. | $147.44 | 2020-2025 | Fanapt |
| Cranial Technologies, INC | $118.06 | 2019-2025 | Doc Band |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $114.29 | 2023-2025 | Caplyta |
| Amgen INC. | $98.38 | 2022-2025 | Repatha, Otezla, Repatha |
| Merck Sharp & Dohme LLC | $89.79 | 2019-2025 | Gardasil 9, Capvaxive, M-M-R II |
| Biohaven Pharmaceutical Holding Company LTD. | $62.16 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $52.36 | 2024-2025 | Rexulti |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $47.87 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $40.99 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $40.51 | 2022-2024 | Eliquis |
| Cleerly, INC. | $39.76 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Abbott Laboratories | $39.15 | 2022-2025 | Freestyle Libre 3 |
| Ultragenyx Pharmaceutical INC. | $36.52 | 2022-2024 | Crysvita |
| Inspire Medical Systems, INC. | $30.13 | 2025 | Inspire |
| Jazz Pharmaceuticals INC. | $29.12 | 2022 | |
| Tms Neurohealth Centers INC. | $24.81 | 2025 | Tms Neurohealth Centers INC. |
| Cumberland Pharmaceuticals, INC. | $22.86 | 2021 | |
| Supernus Pharmaceuticals, INC. | $21.89 | 2020 | |
| Aquestive Therapeutics, INC. | $21.72 | 2024 | |
| Ironshore Pharmaceuticals INC. | $21.58 | 2019 | |
| Baxter Healthcare | $18.92 | 2025 | Hillrom - Monarch Airway Clearance System |
| Axsome Therapeutics, INC. | $18.82 | 2024 | Auvelity |
| Hologic Sales and Service, LLC | $18.76 | 2019 | |
| Mayne Pharma Commercial LLC | $18.10 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.63 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $15.89 | 2025 | Zoryve |
| Novavax INC | $15.49 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Hikma Pharmaceuticals USA | $15.41 | 2021 | |
| Eyevance Pharmaceuticals LLC | $15.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tareq Abedin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.